Brokerage Stock Research Report: Earn huge profits by investing in these stocks, brokerage advises buy somewhere and hold somewhere.

News Topical, Digital Desk : The latest reports from brokerage houses have provided fresh perspectives on the stocks of several large and mid-cap companies. Companies from diverse sectors, from auto batteries to FMCG, pharma, NBFCs, infrastructure, and telecom towers, have been in the brokerage's focus this time around. Ratings on some stocks have been upgraded, target prices have been raised or lowered, while valuation and growth figures have also been clearly discussed. These reports help investors understand which stocks offer buying opportunities and which should be cautious. Significantly, while some stocks have been projected to have strong growth stories, others have been advised to be cautious regarding valuations.

This update includes opinions from major brokerages like Nomura, Jefferies, Morgan Stanley, and CLSA on companies like Exide Industries, Varun Beverages, Pidilite Industries, Mankind Pharma, Bajaj Finance, Aditya Birla Capital, Adani Enterprises, and Indus Towers. These reports indicate that the auto and industrial sectors are expected to recover, discounting is showing its effect in FMCG, asset quality is improving in NBFCs, and growth visibility remains strong in infrastructure-related businesses. Investors can use this information to formulate their strategies.

Nomura has revised its view on Exide Industries. The brokerage has upgraded the stock, assigning a Buy rating and a target price of ₹398. According to the report, third-quarter EBITDA was in line with estimates. Auto sector growth remains strong, and the industrial business is expected to improve further. The brokerage sees EPS growth of 17% between FY26 and FY28.

 Two brokerages are eyeing Varun Beverages. Jefferies has maintained a Buy call on Varun Beverages but has lowered its target to ₹550. According to the brokerage, the decline in prices in India is due to discounting. Management is confident that margins will remain secure and growth will improve during a normal summer season. Morgan Stanley has an Overweight rating on the stock with a target price of ₹522. The brokerage believes that volume growth is likely to remain strong after a weak base, and discounting pressure will ease in the future. 

Hold advice on Pidilite Industries Jefferies has given a Hold rating on Pidilite Industries and has set a target of Rs 1,655. Profit grew 12 per cent year-on-year in the fourth quarter. B2C business remained strong, but the B2B segment lagged due to weak exports. According to the brokerage, the current valuation is expensive. 

Buy maintained on Mankind Pharma Jefferies has maintained a Buy call on Mankind Pharma and has given a target of Rs 2,900. The performance in the third quarter was as per expectations. There are signs of improvement in organic growth and the management expects further recovery. 

Different opinions on Bajaj Finance Morgan Stanley has given an Overweight rating on Bajaj Finance with a target of Rs 1,195. According to the brokerage, asset quality is improving, which will support loan growth. Bernstein has given an Underperform rating on this stock and has a target of Rs 750. However, the asset quality is said to be stable. 

Aditya Birla Capital and Adani Enterprises Morgan Stanley has given Overweight call on Aditya Birla Capital and a target of Rs 432. NBFC, Life Insurance and Housing Finance have all shown good performance. Whereas Jefferies has reduced the target to Rs 2,750 on Adani Enterprises while maintaining Buy call. The brokerage expects growth from airport, copper and solar business in future. 

CLSA has strong opinion on Indus Towers CLSA has given Outperform rating on Indus Towers and has set a target of Rs 560. The core revenue and adjusted EBITDA of the company have been strong. Along with this, expectations of dividend restoration have also been expressed.

Read More: Yes Bank Share: With RBI approval, major changes in Yes Bank management, keep an eye on the stock